Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42.
Expect a significant move up today. Xerri buying back in and little free float. The bid moved up on each buy yesterday. The spread is tighter than it has been.
And they never reply to my direct question of why they are here, commenting on a company in which they are not invested, and do not intend to invest in.